Home > > > > > Report Detail

Global Irritable Bowel Syndrome (IBS) Market Growth 2020-2025

Publisher Name :
Date: 29-Sep-2020
No. of pages: 131

According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 7.8%% CAGR in terms of revenue, the global market size will reach $ 4219.5 million by 2025, from $ 3119.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Irritable Bowel Syndrome (IBS), covering the supply chain analysis, impact assessment to the Irritable Bowel Syndrome (IBS) market size growth rate in several scenarios, and the measures to be undertaken by Irritable Bowel Syndrome (IBS) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- IBS-D Drug

- IBS-C Drug

- Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Women

- Men

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Bausch Health

- Allergan

- Sucampo Pharmaceuticals (Mallinckrodt)

- Sebela Pharmaceuticals Inc

- Takeda

- Astellas Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Irritable Bowel Syndrome (IBS) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.

- Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Irritable Bowel Syndrome (IBS) Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2015-2025
2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
2.2 Irritable Bowel Syndrome (IBS) Segment by Type
2.2.1 IBS-D Drug
2.2.2 IBS-C Drug
2.2.3 Other
2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2015-2020)
2.4 Irritable Bowel Syndrome (IBS) Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Type (2015-2020)
2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2015-2020)

3 Global Irritable Bowel Syndrome (IBS) by Company
3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company
3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Company (2018-2020)
3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2018-2020)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company
3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Company (2018-2020)
3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2018-2020)
3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Company
3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Irritable Bowel Syndrome (IBS) by Regions
4.1 Irritable Bowel Syndrome (IBS) by Regions
4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth

5 Americas
5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020)
5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020)
5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Regions
6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Regions (2015-2020)
6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Regions (2015-2020)
6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020)
7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020)
8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Irritable Bowel Syndrome (IBS) Distributors
10.3 Irritable Bowel Syndrome (IBS) Customer

11 Global Irritable Bowel Syndrome (IBS) Market Forecast
11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2021-2025)
11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2021-2025)
11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application

12 Key Players Analysis
12.1 Bausch Health
12.1.1 Company Information
12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
12.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bausch Health Latest Developments
12.2 Allergan
12.2.1 Company Information
12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
12.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Allergan Latest Developments
12.3 Sucampo Pharmaceuticals (Mallinckrodt)
12.3.1 Company Information
12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
12.3.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
12.4 Sebela Pharmaceuticals Inc
12.4.1 Company Information
12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
12.4.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Sebela Pharmaceuticals Inc Latest Developments
12.5 Takeda
12.5.1 Company Information
12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
12.5.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Takeda Latest Developments
12.6 Astellas Pharmaceuticals
12.6.1 Company Information
12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
12.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Astellas Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Irritable Bowel Syndrome (IBS) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of IBS-D Drug
Table 5. Major Players of IBS-C Drug
Table 6. Major Players of Other
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Table 9. Global Irritable Bowel Syndrome (IBS) Revenue by Type (2015-2020) ($ million)
Table 10. Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Table 14. Global Irritable Bowel Syndrome (IBS) Value by Application (2015-2020)
Table 15. Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2015-2020)
Table 16. Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2015-2020)
Table 17. Global Irritable Bowel Syndrome (IBS) Sales by Company (2017-2019) (Million Units)
Table 18. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2017-2019)
Table 19. Global Irritable Bowel Syndrome (IBS) Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2017-2019)
Table 21. Global Irritable Bowel Syndrome (IBS) Sale Price by Company (2017-2019)
Table 22. Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Irritable Bowel Syndrome (IBS) Products Offered
Table 24. Irritable Bowel Syndrome (IBS) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Irritable Bowel Syndrome (IBS) Consumption by Regions 2015-2020 (Million Units)
Table 26. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2015-2020
Table 27. Global Irritable Bowel Syndrome (IBS) Value by Regions 2015-2020 ($ Millions)
Table 28. Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2015-2020
Table 29. Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020) (Million Units)
Table 30. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2015-2020)
Table 31. Americas Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2015-2020)
Table 33. Americas Irritable Bowel Syndrome (IBS) Consumption by Type (2015-2020) (Million Units)
Table 34. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Table 35. Americas Irritable Bowel Syndrome (IBS) Consumption by Application (2015-2020) (Million Units)
Table 36. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Table 37. APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020) (Million Units)
Table 38. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2015-2020)
Table 39. APAC Irritable Bowel Syndrome (IBS) Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Irritable Bowel Syndrome (IBS) Value Market Share by Regions (2015-2020)
Table 41. APAC Irritable Bowel Syndrome (IBS) Consumption by Type (2015-2020) (Million Units)
Table 42. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Table 43. APAC Irritable Bowel Syndrome (IBS) Consumption by Application (2015-2020) (Million Units)
Table 44. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Table 45. Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020) (Million Units)
Table 46. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2015-2020)
Table 47. Europe Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2015-2020)
Table 49. Europe Irritable Bowel Syndrome (IBS) Consumption by Type (2015-2020) (Million Units)
Table 50. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Table 51. Europe Irritable Bowel Syndrome (IBS) Consumption by Application (2015-2020) (Million Units)
Table 52. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2015-2020) (Million Units)
Table 54. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type (2015-2020) (Million Units)
Table 58. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application (2015-2020) (Million Units)
Table 60. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Table 61. Irritable Bowel Syndrome (IBS) Distributors List
Table 62. Irritable Bowel Syndrome (IBS) Customer List
Table 63. Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Countries (2021-2025) (Million Units)
Table 64. Global Irritable Bowel Syndrome (IBS) Consumption Market Forecast by Regions
Table 65. Global Irritable Bowel Syndrome (IBS) Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Regions
Table 67. Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Type (2021-2025) (Million Units)
Table 68. Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Irritable Bowel Syndrome (IBS) Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Type (2021-2025)
Table 71. Global Irritable Bowel Syndrome (IBS) Consumption Forecast by Application (2021-2025) (Million Units)
Table 72. Global Irritable Bowel Syndrome (IBS) Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Irritable Bowel Syndrome (IBS) Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Irritable Bowel Syndrome (IBS) Value Market Share Forecast by Application (2021-2025)
Table 75. Bausch Health Product Offered
Table 76. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 77. Bausch Health Main Business
Table 78. Bausch Health Latest Developments
Table 79. Bausch Health Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 80. Allergan Product Offered
Table 81. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 82. Allergan Main Business
Table 83. Allergan Latest Developments
Table 84. Allergan Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 85. Sucampo Pharmaceuticals (Mallinckrodt) Product Offered
Table 86. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 87. Sucampo Pharmaceuticals (Mallinckrodt) Main Business
Table 88. Sucampo Pharmaceuticals (Mallinckrodt) Latest Developments
Table 89. Sucampo Pharmaceuticals (Mallinckrodt) Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 90. Sebela Pharmaceuticals Inc Product Offered
Table 91. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 92. Sebela Pharmaceuticals Inc Main Business
Table 93. Sebela Pharmaceuticals Inc Latest Developments
Table 94. Sebela Pharmaceuticals Inc Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Product Offered
Table 96. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. Takeda Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors
Table 100. Astellas Pharmaceuticals Product Offered
Table 101. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2018-2020E)
Table 102. Astellas Pharmaceuticals Main Business
Table 103. Astellas Pharmaceuticals Latest Developments
Table 104. Astellas Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Irritable Bowel Syndrome (IBS) Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Irritable Bowel Syndrome (IBS)
Figure 2. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate 2015-2025 (Million Units)
Figure 5. Global Irritable Bowel Syndrome (IBS) Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of IBS-D Drug
Figure 7. Product Picture of IBS-C Drug
Figure 8. Product Picture of Other
Figure 9. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2015-2020)
Figure 10. Global Irritable Bowel Syndrome (IBS) Value Market Share by Type (2015-2020)
Figure 11. Irritable Bowel Syndrome (IBS) Consumed in Women
Figure 12. Global Irritable Bowel Syndrome (IBS) Market: Women (2015-2020) (Million Units)
Figure 13. Global Irritable Bowel Syndrome (IBS) Market: Women (2015-2020) ($ Millions)
Figure 14. Irritable Bowel Syndrome (IBS) Consumed in Men
Figure 15. Global Irritable Bowel Syndrome (IBS) Market: Men (2015-2020) (Million Units)
Figure 16. Global Irritable Bowel Syndrome (IBS) Market: Men (2015-2020) ($ Millions)
Figure 17. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2015-2020)
Figure 18. Global Irritable Bowel Syndrome (IBS) Value Market Share by Application (2015-2020)
Figure 19. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2017
Figure 20. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 21. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company in 2017
Figure 22. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company in 2019
Figure 23. Global Irritable Bowel Syndrome (IBS) Sale Price by Company in 2019
Figure 24. Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Regions 2015-2020
Figure 25. Global Irritable Bowel Syndrome (IBS) Value Market Share by Regions 2015-2020
Figure 26. Americas Irritable Bowel Syndrome (IBS) Consumption 2015-2020 (Million Units)
Figure 27. Americas Irritable Bowel Syndrome (IBS) Value 2015-2020 ($ Millions)
Figure 28. APAC Irritable Bowel Syndrome (IBS) Consumption 2015-2020 (Million Units)
Figure 29. APAC Irritable Bowel Syndrome (IBS) Value 2015-2020 ($ Millions)
Figure 30. Europe Irritable Bowel Syndrome (IBS) Consumption 2015-2020 (Million Units)
Figure 31. Europe Irritable Bowel Syndrome (IBS) Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2015-2020 (Million Units)
Figure 33. Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2015-2020 ($ Millions)
Figure 34. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2019
Figure 35. Americas Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2019
Figure 36. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2019
Figure 37. Americas Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2019
Figure 38. United States Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 39. United States Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 41. Canada Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 43. Mexico Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2019
Figure 45. APAC Irritable Bowel Syndrome (IBS) Value Market Share by Regions in 2019
Figure 46. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2019
Figure 47. APAC Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2019
Figure 48. China Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 49. China Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 51. Japan Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 53. Korea Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 55. Southeast Asia Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 56. India Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 57. India Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 59. Australia Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2019
Figure 61. Europe Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2019
Figure 62. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2019
Figure 63. Europe Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2019
Figure 64. Germany Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 65. Germany Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 66. France Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 67. France Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 68. UK Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 69. UK Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 71. Italy Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 73. Russia Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Irritable Bowel Syndrome (IBS) Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Market Share by Application in 2019
Figure 78. Egypt Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 79. Egypt Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 81. South Africa Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 83. Israel Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 85. Turkey Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Irritable Bowel Syndrome (IBS) Consumption Growth 2015-2020 (Million Units)
Figure 87. GCC Countries Irritable Bowel Syndrome (IBS) Value Growth 2015-2020 ($ Millions)
Figure 88. Global Irritable Bowel Syndrome (IBS) Consumption Growth Rate Forecast (2021-2025) (Million Units)
Figure 89. Global Irritable Bowel Syndrome (IBS) Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 91. Americas Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 92. APAC Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 93. APAC Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 94. Europe Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 95. Europe Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 97. Middle East & Africa Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 98. United States Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 99. United States Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 100. Canada Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 101. Canada Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 102. Mexico Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 103. Mexico Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 104. Brazil Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 105. Brazil Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 106. China Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 107. China Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 108. Japan Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 109. Japan Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 110. Korea Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 111. Korea Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 113. Southeast Asia Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 114. India Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 115. India Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 116. Australia Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 117. Australia Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 118. Germany Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 119. Germany Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 120. France Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 121. France Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 122. UK Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 123. UK Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 124. Italy Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 125. Italy Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 126. Russia Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 127. Russia Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 128. Spain Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 129. Spain Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 130. Egypt Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 131. Egypt Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 132. South Africa Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 133. South Africa Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 134. Israel Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 135. Israel Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 136. Turkey Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 137. Turkey Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Irritable Bowel Syndrome (IBS) Consumption 2021-2025 (Million Units)
Figure 139. GCC Countries Irritable Bowel Syndrome (IBS) Value 2021-2025 ($ Millions)
Figure 140. Bausch Health Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
Figure 141. Allergan Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
Figure 142. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
Figure 143. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
Figure 144. Takeda Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
Figure 145. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share (2018-2020)
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs